Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Colorectal cancer statistics, 2020
2020 Standout
Global Effect of PEG-IFN- α and Ribavirin on Gene Expression in PBMC In Vitro
2004
Colorectal cancer statistics, 2023
2023 Standout
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion
2017
mRECIST for HCC: Performance and novel refinements
2020
Astrocytes: biology and pathology
2009 Standout
Signaling factors in the mechanism of ammonia neurotoxicity
2008
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Molecular dissection of reactive astrogliosis and glial scar formation
2009 Standout
FLUID RESUSCITATION IN SEVERE SEPSIS AND SEPTIC SHOCK
2007
Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
2016
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
2004
Budd–Chiari syndrome: a review by an expert panel
2003
Management of patients with hepatitis B who require immunosuppressive therapy
2013
Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
2016
Left-Liver Hypertrophy After Therapeutic Right-Liver Radioembolization Is Substantial but Less Than After Portal Vein Embolization
2013
Burden of liver diseases in the world
2018 Standout
Management of ectopic varices
1998
Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites
1997
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation
2006
Role of glutamine in cerebral nitrogen metabolism and ammonia neurotoxicity
2001
Antithrombotic Therapy for VTE Disease
2016 Standout
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Hepatocellular carcinoma
2021 Standout
TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy
2002
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Hepatic circulation: Potential for therapeutic intervention
1990
Treatments for colorectal liver metastases: A new focus on a familiar concept
2016
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis
2005
Calcium in the mechanism of ammonia‐induced astrocyte swelling
2009
Vascular disorders of the liver # †
2008 Standout
High incidence of recurrence and hematologic events following liver transplantation for Budd–Chiari syndrome
2005
Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma
2016
Antithrombotic Therapy for VTE Disease
2012 Standout
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
2007
Portal hypertensive bleeding in cirrhosis
2016 Standout
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018
Pathogenesis and Treatment of Budd-Chiari Syndrome Combined with Portal Vein Thrombosis
2006
Treatment of Budd‐Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto‐systemic shunt and liver transplantation
2004
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
2007 Standout
Acute Liver Failure
1993
The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy
1997
Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
2015
Procedimientos radiológicos intervencionistas, angioplastia y DPPI en el tratamiento del síndrome de Budd-Chiari
2003
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma
2014
Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome
2003
Optimal management of hepatitis B virus infection – EASL Special Conference
2015
AGA technical review on intestinal ischemia
2000 Standout
The Utility of TIPS in the Management of Budd-Chiari Syndrome
2005
Global burden of liver disease: 2023 update
2023 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines
2013
Erratum to: Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
2017
Mechanisms of Ammonia-Induced Astrocyte Swelling
2005
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center
2013
Albumin Therapy in Clinical Practice
2005
Adaptive immunity in HBV infection
2016
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
Repeat Interventions for Maintenance of Transjugular Intrahepatic Portosystemic Shunt Function in Patients with Budd-Chiari Syndrome
2002
Acute Budd–Chiari syndrome with liver failure: The experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt
2004
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
2021
Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
2016
Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy
2016
Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings
1998
Glutamine, Myo –Inositol, and Organic Brain Osmolytes After Portocaval Anastomosis in the Rat: Implications for Ammonia–Induced Brain Edema
1996
Intravenous Fluids and Acute Kidney Injury
2017 Standout
Ammonia-induced astrocyte swelling in primary culture
1991
Clinical features, diagnosis and outcome of acute portal vein thrombosis
2000
PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome
2004
Hepatocellular carcinoma
2022 Standout
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
2007
The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt
2004
Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy
2015
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Hepatocellular Carcinoma
2019 Standout
Severe Alcohol‐Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure
2021
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Mesenteric venous thrombosis
1989
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
2019
Patient Survival after Human Albumin Administration
2001
Prevention and Treatment of Cancer-Related Infections
2012
Hepatitis B reactivation in HBsAg‐negative/HBcAb‐positive patients receiving rituximab for lymphoma: a meta‐analysis
2015
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
2013
Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy
2014
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System
2017
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Yttrium‐90 radioembolization vs sorafenib for intermediate‐locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis
2014
Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy
2017
Colorectal cancer statistics, 2017
2017 Standout
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma
2016
Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series
2017
Protein C, protein S and antithrombin III in children with portal vein obstruction
1997
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
2020
Transarterial Chemoembolization and Radioembolization
2014
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
2021
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit
2004 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma
2015
Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
2021
Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection
2015
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
2002 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: The Emerging Role for Radioembolization Using Yttrium-90
2013
Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States
2015
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma
2014
Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
2014
Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis
2017
Eight‐Fold Increase in Dietary Supplement–Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States
2021
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
1998 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey
2017
Works of Daniel Ganger being referenced
An Analysis of Acute Changes in Interleukin-6 Levels After Treatment of Hepatitis C with Consensus Interferon
2001
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
2010
Changes in frailty are associated with waitlist mortality in patients with cirrhosis
2020
Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization
2017
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
2016
Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma
2018
Randomized, double-blind study of intravenous human albumin in hypoalbuminemic patients receiving total parenteral nutrition
1997
Development and Pilot of a Checklist for Management of Acute Liver Failure in the Intensive Care Unit
2016
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Budd-Chiari Syndrome or Portal Vein Thrombosis
1999
Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury
2016
Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection
2013
Duodenal Varices: A Case Report and Review of the Literature
1995
Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib
2013
Prospective Evaluation of Patients with Early-/Intermediate-stage Hepatocellular Carcinoma with Disease Progression Following Arterial Locoregional Therapy: Candidacy for Systemic Treatment or Clinical Trials
2013
Prospective randomized pilot study of Y90 +/− sorafenib as bridge to transplantation in hepatocellular carcinoma
2014
Organic nitrates in portal hypertension
1988
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: Impact of liver function on systemic treatment options at disease progression
2012
Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization
2013
Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma
2016
Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study
2019
Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: Ultrastructure and integrity of the blood-brain barrier
1987
Unresectable Solitary Hepatocellular Carcinoma Not Amenable to Radiofrequency Ablation: Multicenter Radiology-Pathology Correlation and Survival of Radiation Segmentectomy
2014
Hemodynamic and renal effects of atrial natriuretic factor in portal hypertensive rats. Potentiation by Phe-Ile-Orn-vasopressin.
1988
Protein C deficiency in splanchnic venous thrombosis
1987
Transjugular intrahepatic portosystemic shunt in nonliver transplant candidates: is it indicated?
1995
Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis
1987
Radioembolization for hepatocellular carcinoma: Statistical confirmation of improved survival in responders by landmark analyses
2017
Comparative Study of Staging Systems for Hepatocellular Carcinoma in 428 Patients Treated with Radioembolization
2014
Association Between Liver Transplant Wait-list Mortality and Frailty Based on Body Mass Index
2019
Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates
2020
Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage
2016
Effect of Body Temperature on Brain Edema and Encephalopathy in the Rat After Hepatic Devascularization
1989
Two‐year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study
2014
Brain edema in rabbits with galactosamine-induced fulminant hepatitis
1986
Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari Syndrome or portal vein thrombosis Review of indications and problems
1999
Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study
2020